Literature DB >> 6361072

Microdeposits of amyloid in sclerocalcific heart valves: a histochemical and immunofluorescence study.

Y A Goffin, W Murdoch, G G Cornwell, G D Sorenson.   

Abstract

Amyloid associated with seven sclerotic and two normal aortic and mitral valves was studied. The sclerotic valve amyloid contained microfibrils with typical random orientation and a fibril width of 9.5-12.5 nm. The amyloid deposits demonstrated permanganate-resistant Congophilia and contained the amino acid tryptophan. Immunofluorescence studies showed P-component in amyloid deposits of 6 of 7 valves, but none of the sclerotic valves contained amyloid fibril proteins of the AL (primary), AA (secondary), AEt (medullary thyroid carcinoma) or ASc1 (senile cardiac) types. Two non-sclerotic valves, removed from a patient with systemic amyloidosis, showed permanganate-sensitive Congophilic amyloid deposits which contained amyloid fibril protein AA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6361072      PMCID: PMC498565          DOI: 10.1136/jcp.36.12.1342

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Histochemical similarity of senile plaque amyloid to apudamyloid.

Authors:  J M Powers; S S Spicer
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-11-17

Review 2.  Relationship of amyloid to aging. Review of the literature and systematic study of 83 patients derived rom a general hospital population.

Authors:  J R Wright; E Calkins; W J Breen; G Stolte; R T Schultz
Journal:  Medicine (Baltimore)       Date:  1969-01       Impact factor: 1.889

3.  Clinically significant cardiac amyloidosis. Clinicopathologic findings in 15 patients.

Authors:  L M Buja; N B Khoi; W C Roberts
Journal:  Am J Cardiol       Date:  1970-10       Impact factor: 2.778

4.  Amyloid P-component (protein AP) in localized amyloidosis as revealed by an immunocytochemical method.

Authors:  P Westermark; T Shirahama; M Skinner; P Norén; A S Cohen
Journal:  Histochemistry       Date:  1981

5.  Senile cardiac amyloidosis: evidence of two different amyloid substances in the ageing heart.

Authors:  P Westermark; B Johansson; J B Natvig
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

6.  High-resolution electron microscopic analysis of the amyloid fibril in Alzheimer's disease.

Authors:  H K Narang
Journal:  J Neuropathol Exp Neurol       Date:  1980-11       Impact factor: 3.685

7.  Senile cardiac amyloid: demonstration of a unique fibril protein in tissue sections.

Authors:  G G Cornwell; J B Natvig; P Westermark; G Husby
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

8.  Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.

Authors:  J R Wright; E Calkins; R L Humphrey
Journal:  Lab Invest       Date:  1977-03       Impact factor: 5.662

9.  Identification and characterization of different amyloid fibril proteins in tissue sections.

Authors:  G G Cornwell; G Husby; P Westermark; J B Natvig; T E Michaelsen; B Skogen
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

10.  Microscopic amyloid deposits in the heart valves: a common local complication of chronic damage and scarring.

Authors:  Y Goffin
Journal:  J Clin Pathol       Date:  1980-03       Impact factor: 3.411

View more
  3 in total

1.  Histotopographic evidence that amyloid deposits in sclerocalcific heart valves and other chronic lesions of the cardiovascular system are related to old thrombotic material.

Authors:  Y A Goffin; F Rickaert
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 2.  The age related amyloids: a growing family of unique biochemical substances.

Authors:  G G Cornwell; K H Johnson; P Westermark
Journal:  J Clin Pathol       Date:  1995-11       Impact factor: 3.411

Review 3.  Amyloid in the cardiovascular system: a review.

Authors:  I Kholová; H W M Niessen
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.